Proinsulin humanAlternative Names: LY 167005
Latest Information Update: 21 Jan 1998
At a glance
- Originator Eli Lilly; Genentech
- Class Antihyperglycaemics; Insulins
- Mechanism of Action Phosphokinase stimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Diabetes mellitus